It’s not. That’s what a lot of people don’t understand.
These drugs from Vertex started being approved in 2014. US insurers pretty much covered them from approval. Even Medicaid (health insurance for low income) started paying for it.
Other countries? The UK just started in 2020.
In Canada? Last I checked only 5 of the 10 provinces paid for it and only if you’re under 18.
The US healthcare is expensive for a lot of reasons, and one of them is new technology gets paid for really quickly.
Of course, it's Canada, so you may have private drug coverage and then it depends on province whether you fall back to the public coverage if the private payor doesn't cover it.
> The third-generation of modulators, Trikafta, is a new transformational drug that can treat up to 90% of Canadians with cystic fibrosis. Trikafta was approved for sale in Canada on Friday, June 18th, 2021, by Health Canada for people aged 12 and up with cystic fibrosis and at least one F508del mutation and on April 20, 2022 for those aged six and up. As of September 13, 2022, every province, territory and federal drug program is funding this drug for those six and up. Unfortunately, it is not accessible to all who can benefit from it, and therefore our advocacy work continues
These drugs from Vertex started being approved in 2014. US insurers pretty much covered them from approval. Even Medicaid (health insurance for low income) started paying for it.
Other countries? The UK just started in 2020.
In Canada? Last I checked only 5 of the 10 provinces paid for it and only if you’re under 18.
The US healthcare is expensive for a lot of reasons, and one of them is new technology gets paid for really quickly.